Zabiegowe leczenie omdleń wazowagalnych, bloku AV i dysfunkcji węzła zatokowego. Kardioneuroablacja jako alternatywa dla kardiostymulatorów

Patrycja Agnieszka Białowąs; Tomasz Senderek; Piotr Kopiński

doi:10.48269/2451-0858-pis-2024-2-011

Published: 2024-12-18

Vol. 24 No. 2 (2024)

Treatment of vasovagal syncope, AV block and sinus node dysfunction: Cardioneuroablation as an alternative to pacemakers

Patrycja Agnieszka Białowąs

, Tomasz Senderek

, Piotr Kopiński

Section: Health Sciences

https://doi.org/10.48269/2451-0858-pis-2024-2-011

Abstract

Over the years, various attempts have been made to treat vasovagal syncope, AV block and sinus node dysfunction. Scientific research has excluded pharmacological treatment with beta-blockers as an effective therapy for these diseases. Current ESC guidelines recommend the use of pacemakers in these cases. The implantation of dual-chamber devices is highly effective in alleviating symptoms. However, this involves reoperation in the future to replace the device’s battery. This problem especially concerns young patients, in whom several reoperations are expected. This increases the risk of local and systemic infections. A new method of treatment is cardioneuroablation (CNA). It destroys the ganglion nodes with a radiofrequency current to reduce the parasympathetic component. Thanks to the modulation, the positive chronotropic effect on the heart is strengthened. The effectiveness of CNA ranges from 80 to 100%. CNA is also characterized by a low perioperative risk.

Keywords:

syncope , cardioneuroablation , ablation , AV block

Download files

PDF (Język polski)

Citation rules

Białowąs, Patrycja Agnieszka, et al. “Treatment of Vasovagal Syncope, AV Block and Sinus Node Dysfunction: Cardioneuroablation As an Alternative to Pacemakers”. Państwo I Społeczeństwo State and Society, vol. 24, no. 2, Dec. 2024, pp. 153-67, doi:10.48269/2451-0858-pis-2024-2-011.

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

Główny Urząd Statystyczny. Umieralność w 2021. Zgony według przyczyn – dane wstępne, 16.05.2022; https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5746/10/3/1/umieralnosc_i_zgony_wedlug_przyczyn_w_2021_roku.pdf [dostęp: 7.11.2024].
Google Scholar

Sielski J, Janion-Sadowska A, Wałek P. Czy istnieją istotne różnice w stałej stymulacji serca u pacjentów w wieku podeszłym: na podstawie materiału Ośrodka Implantacji Stymulatorów Serca Świętokrzyskiego Centrum Kardiologii w Kielcach. Studia Medyczne. 2012; 2: 7–14.
Google Scholar

Machejek J, Lelakowski J, Bednarek J, Majewski J. Elektrostymulacja serca w Krakowie w latach 1966–1980. Przegląd Lekarski. 2003; 60(1): 49–56.
Google Scholar

Jaguś-Jamioła A, Cissowska M, Kowal J, Kaźmierczak-Dziuk A. Elektrostymulacja serca – nowoczesna metoda leczenia zaburzeń rytmu i przewodzenia. Postępowanie u chorego z wszczepionym układem stymulującym serce lub kardiowerterem-defibrylatorem. Pediatr Med Rodz. 2012; 8(2): 137–147.
Google Scholar

Bryl M, Guzik P. Wpływ pola elektromagnetycznego związanego z elektrokoagulacją na funkcje kardiologicznych urządzeń wszczepialnych i postępowanie okołooperacyjne. Anestezjologia i Ratownictwo. 2012; 6: 204–211.
Google Scholar

Burri H, Jastrzebski M, Cano Ó, Čurila K, de Pooter J, Huang W, Israel C, Joza J, Romero J, Vernooy K, Vijayaraman P, Whinnett Z, Zanon F. EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS),Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS). EP Europace. 2023; 25(4): 1208–1236, https://doi.org/10.1093/europace/euad043.
Google Scholar

Kargul W, Młynarski R, Piłat E. Implantowanie stymulatorów serca i kardiowerterów-defibrylatorów / Implantation of pacemakers and cardioverter-defibrillators. Chirurgia Polska. 2005; 7(4): 267–279.
Google Scholar

Kaszala K, Huizar JF, Ellenbogen KA. Contemporary Pacemakers: What the Primary Care Physician Needs to Know. Mayo Clin Proc. 2008; 83(10): 1170–1186.
Google Scholar

Kardiologia Polska. 2009; 67(12, supl 8): Wytyczne Europejskiego Towarzystwa Kardiologicznego dotyczące diagnostyki i postępowania w omdleniach (wersja 2009).
Google Scholar

Kapoor WN. Evaluation and outcome of patients with syncope. Medicine. 1990; 69(3): 160–175, https://doi.org/10.1097/00005792-199005000-00004.
Google Scholar

van Dijk JG, van Rossum IA, Thijs RD. The pathophysiology of vasovagal syncope: Novel insights. Auton Neurosci. 2021; 236: 102899, https://doi.org/10.1016/j.autneu.2021.102899.
Google Scholar

Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C, Talajic M, Ku T, Fouad-Tarazi F, Ritchie D, Koshman ML; POST Investigators. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation. 2006; 113(9): 1164–1170, https://doi.org/10.1161/CIRCULATIONAHA.105.535161.
Google Scholar

Madrid AH, Ortega J, Rebollo JG, Manzano JG, Segovia JG, Sánchez A, Peña G, Moro C. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol. 2001; 37(2): 554–559, https://doi.org/10.1016/s0735-1097(00)01155-4.
Google Scholar

Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W, Andresen D, Benditt DG, Vardas P; International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J. 2006; 27(9): 1085–1092, https://doi.org/10.1093/eurheartj/ehi842.
Google Scholar

Sud S, Klein GJ, Skanes AC, Gula LJ, Yee R, Krahn AD. Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope. Europace. 2007; 9(5): 312–318, https://doi.org/10.1093/europace/eum020.
Google Scholar

Sutton R. Should we treat severe vasovagal syncope with a pacemaker?. J Intern Med. 2017; 281(6): 554–561, https://doi.org/10.1111/joim.12603.
Google Scholar

Palmisano P, Zaccaria M, Luzzi G, Nacci F, Anaclerio M, Favale S. Closed-loop cardiac pacing vs. conventional dual-chamber pacing with specialized sensing and pacing algorithms for syncope prevention in patients with refractory vasovagal syncope: results of a long-term follow-up. EP Europace. 2012; 14(7): 1038–1043, https://doi.org/10.1093/europace/eur419.
Google Scholar

Sutton R, Brignole M, Menozzi C, Raviele A, Alboni P, Giani P, Moya A. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation. 2000; 102(3): 294–299, https://doi.org/10.1161/01.cir.102.3.294.
Google Scholar

Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD, Wieling W, Beiras X, Deharo JC, Russo V, Tomaino M, Sutton R; International Study on Syncope of Uncertain Etiology 3 (ISSUE-3) Investigators. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation. 2012; 125(21): 2566–2571, https://doi.org/10.1161/CIRCULATIONAHA.111.082313.
Google Scholar

van Eck JWM, van Hemel NM, van den Bos A, Taks W, Grobbee DE, Moons KGM. Predictors of improved quality of life 1 year after pacemaker implantation. Am Heart J. 2008; 156(3): 491–497, https://doi.org/10.1016/j.ahj.2008.04.029.
Google Scholar

Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, Morillo C, Gent M; VPS II Investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA. 2003; 289(17): 2224–2229, https://doi.org/10.1001/jama.289.17.2224.
Google Scholar

Ellenbogen KA, Hellkamp AS, Wilkoff BL, Camunãs JL, Love JC, Hadjis TA, Lee KL, Lamas GA. Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol. 2003; 92(6): 740–741, https://doi.org/10.1016/s0002-9149(03)00844-0.
Google Scholar

Senderek T, Majewski JP, Lelakowski J. Haemoptysis as a complication of pacemaker implantation. Europace. 2012; 14(2): 203, https://doi.org/10.1093/europace/eur361.
Google Scholar

Michałkiewicz D, Kutarski A. Infekcja loży po pierwszej implantacji układu oraz po zabiegu powtórnym – różnice. Specyfika postępowania antyseptycznego przy implantacji i reoperacji układu stymulującego – elementy dyskusyjne. Folia Cardiologica Excerpta. 2009; 4(2): 73–77.
Google Scholar

Domagała S, Domagała M, Chyła J, Wojciechowska C, Janion M, Polewczyk A. Complications of electrotherapy – the dark side of treatment with cardiac implantable electronic devices. Adv Interv Cardiol. 2018; 14(1): 15–25, https://doi.org/10.5114/aic.2018.74351.
Google Scholar

Lelakowski J. Rozpoznawanie bakteryjnego zapalenia wsierdzia. Folia Cardiologica Excerpta. 2009; 4(2): 78–82.
Google Scholar

Bongiorni MG, Tascini C, Tagliaferri E, Di Cori A, Soldati E, Leonildi A, Zucchelli G, Ciullo I, Menichetti F. Microbiology of cardiac implantable electronic device infections. EP Europace. 2012; 14(9): 1334–1339, https://doi.org/10.1093/europace/eus044.
Google Scholar

Udo EO, Zuithoff NPA, van Hemel NM, de Cock CC, Hendriks T, Doevendans PA, Moons KGM. Incidence and predictors of short- and long-term complications in pacemaker therapy: The FOLLOWPACE study. Heart Rhythm. 2012; 9(5): 728–735, https://doi.org/10.1016/j.hrthm.2011.12.014.
Google Scholar

Uslan DZ, Sohail MR, St. Sauver JL, Friedman PA, Hayes DL, Stoner SM, Wilson WR, Steckelberg JM, Baddour LM. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007; 167(7): 669–675, https://doi.org/10.1001/archinte.167.7.669.
Google Scholar

Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner S, Baddour LM. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007; 49(18): 1851–1859, https://doi.org/10.1016/j.jacc.2007.01.072.
Google Scholar

Wożakowska-Kapłon B, Wesołowska K, Kutarski A. Odelektrodowe zapalenie wsierdzia jako późne powikłanie po implantacji stymulatora serca. Kardiol Pol. 2011; 69(3): 265–269.
Google Scholar

Koźluk E, Piątkowska A, Rodkiewiecz D, Kowalczuk N, Opolski G. Kardioneuroablacja w omdleniach odruchowych – nowa nadzieja dla trudnych pacjentów. Forum Medycyny Rodzinnej. 2019; 13(5): 223–231.
Google Scholar

Pachon-M JC, Pachon-M EI, Pachon-M JC, Lobo TJ, Pachon MZ, Vargas RN, Jatene AD. “Cardioneuroablation” – New treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace. 2005; 7(1): 1–13, https://doi.org/10.1016/j.eupc.2004.10.003.
Google Scholar

Piotrowski R, Baran J, Kułakowski P. Cardioneuroablation using an anatomical approach: a new and promising method for the treatment of cardioinhibitory neurocardiogenic syncope. Kardiol Pol. 2018; 76(12): 1736–1738, https://doi.org/10.5603/KP.a2018.0200.
Google Scholar

Aksu T, Davila A, Gupta D. The “heartbrain” and neuromodulation for vasovagal syncope. Auton Neurosci. 2021; 236: 102892, https://doi.org/10.1016/j.autneu.2021.102892.
Google Scholar

Pachon-M JC, Pachon-M EI, Differential effects of ganglionic plexi ablation in a patient with neurally mediated syncope and intermittent atrioventricular block: a commentary. EP Europace. 2017; 19(1): 1–3, https://doi.org/10.1093/europace/euw133.
Google Scholar

Pachon-M JC, Pachon-M EI, Cunha Pachon MZ, Lobo TJ, Pachon-M JC, Santillana-P TG. Catheterablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results. Europace. 2011; 13(9): 1231–1242, https://doi.org/10.1093/europace/eur163.
Google Scholar

Brignole M, Moya A, de Lange JF, DeharoJ-C, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martin A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG. Wytyczne ESC dotyczące rozpoznawania i leczenia omdleń (2018). Kardiologia Polska. 2018; 76(8): 1119–1198, https://doi.org/10.5603/KP.2018.0161.
Google Scholar

Tułecki Ł, Polewczyk A, Jacheć W, Nowosielecka D, Tomków K, Stefańczyk P, Kosior J, Duda K, Polewczyk M, Kutarski A. A Study of Major and Minor Complications of 1500 Transvenous Lead Extraction Procedures Performed with Optimal Safety at Two High-Volume Referral Centers. Int J Environ Res Public Health. 2021; 18(19): 10416, https://doi.org/10.3390/ijerph181910416.
Google Scholar

Patrycja Agnieszka Białowąs

bialowaspatrycja@gmail.com
https://orcid.org/0000-0002-8913-3656

Affiliation:

Andrzej Frycz Modrzewski Krakow University, Poland

Tomasz Senderek

https://orcid.org/0000-0001-5937-5905

Affiliation:

Andrzej Frycz Modrzewski Krakow University, Poland

Piotr Kopiński

https://orcid.org/0000-0002-7532-1226

Affiliation:

(1) Uniwersytet Andrzeja Frycza Modrzewskiego w Krakowie, Collegium Medicum – Wydział Lekarski, Katedra Fizjologii i Patofizjologii; (2) Krakowski Szpital Specjalistyczny im. Św. Jana Pawła II, Pracownia Biologii Molekularnej; (3) Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy – Wydział Lekarski, Katedra Chorób Płuc, Nowotworów i Gruźlicy, Poland